Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07146854 · ClinicalTrials.gov registry record

EndoForce Post Approval Study

A clinical trial of End Stage Renal Disease (ESRD), sponsored by Phraxis.

Recruiting
Registry status
150
Enrollment target
2
Study locations

NCT07146854 is a study of End Stage Renal Disease (ESRD) that is actively recruiting participants, run by Phraxis. The registered enrollment target is 150 participants, below the 361-participant average among 10 other End Stage Renal Disease (ESRD) trials with a reported enrollment target (58% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07146854, a study of End Stage Renal Disease (ESRD), is actively recruiting participants, sponsored by Phraxis.

RECRUITING
Registry status
150 participants
Enrollment target
2
Study locations

Study Summary

The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.

Conditions Studied

End Stage Renal Disease (ESRD)

Study Locations (2)

South Carolina

  • MUSC Health Orangeburg - Orangeburg
  • Spartanburg Regional Medical Center - Spartanburg

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2026-01-13
Est. Completion 2029-12

Sponsor

Phraxis

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07146854

The ClinicalTrials.gov registry entry for NCT07146854 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 361-participant average among 10 other End Stage Renal Disease (ESRD) trials with a reported enrollment target (58% lower). The listed sponsor is Phraxis, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease (ESRD) appearing as the primary indexed condition, and to 0 interventions.

NCT07146854 reports 2 study locations spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT07146854 about?

NCT07146854 is a clinical study titled "EndoForce Post Approval Study". The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the s...

What is the current status of trial NCT07146854?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2026-01-13. Estimated completion is 2029-12.

What conditions does trial NCT07146854 study?

This clinical trial studies the following conditions: End Stage Renal Disease (ESRD).

Who is sponsoring clinical trial NCT07146854?

This trial is sponsored by Phraxis, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07146854 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease (ESRD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease (ESRD)

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.